| ANKRD36B |
Q8N2N9
|
ankyrin repeat domain 36B
|
|
|
0.584 |
0.500 |
| DUX4 |
Q9UBX2
|
double homeobox 4
|
|
|
0.604 |
0.500 |
| H3P12 |
|
H3 histone pseudogene 12
|
|
|
0.603 |
0.615 |
| SSX2B |
Q16385
|
SSX family member 2B
|
|
|
0.599 |
0.577 |
| PSC |
|
Cholangitis, primary sclerosing
|
|
|
0.603 |
0.731 |
| CASC2 |
|
cancer susceptibility 2
|
|
|
0.612 |
0.462 |
| LEPQTL1 |
|
Leptin, serum levels of
|
|
|
0.638 |
0.385 |
| SIK1B |
A0A0B4J2F2 P57059
|
salt inducible kinase 1B (putative)
|
|
|
0.653 |
0.385 |
| MIR622 |
|
microRNA 622
|
|
|
0.638 |
0.500 |
| MAGEC2 |
Q9UBF1
|
MAGE family member C2
|
Cell adhesion
|
|
0.656 |
0.500 |
| ZNF667-AS1 |
|
ZNF667 antisense RNA 1 (head to head)
|
|
|
0.691 |
0.308 |
| MIR761 |
|
microRNA 761
|
|
|
0.682 |
0.308 |
| C11orf95 |
C9JLR9
|
chromosome 11 open reading frame 95
|
|
|
0.780 |
0.115 |
| CMD1B |
|
cardiomyopathy, dilated 1B (autosomal dominant)
|
|
|
0.722 |
0.500 |
| MIR1226 |
|
microRNA 1226
|
|
|
0.792 |
0.269 |
| MXLPO |
|
Myxoid liposarcoma
|
|
|
0.769 |
0.154 |
| C3CER1 |
|
chromosome 3 common eliminated region 1
|
|
|
0.839 |
0.231 |
| RPSAP52 |
|
ribosomal protein SA pseudogene 52
|
|
|
0.931 |
0.154 |
| OS4 |
|
Osteoarthritis, generalized, without dysplasia, susceptibility to
|
|
|
|
|
| MUC16 |
Q8WXI7
|
mucin 16, cell surface associated
|
|
8.3E-112 |
0.479 |
0.808 |
| MIB1 |
Q86YT6
|
mindbomb E3 ubiquitin protein ligase 1
|
Enzyme
|
3.4E-88 |
0.438 |
0.769 |
| ROS1 |
P08922
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
Kinase
|
1.6E-72 |
0.439 |
0.885 |
| MUC4 |
Q99102
|
mucin 4, cell surface associated
|
|
2.8E-54 |
0.506 |
0.769 |
| ABCC2 |
Q92887
|
ATP binding cassette subfamily C member 2
|
Transporter
|
5.2E-47 |
0.483 |
0.808 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |